EU TRANSPARENCY REGISTER · 045767293922-02 · United States

Regeneron Pharmaceuticals Inc.

Category

Companies & groups

Country

United States

Tarrytown

Entity form

Corporation

Stated objectives

Regeneron is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, Regeneron's unique ability to repeatedly and cons…

As declared by the registrant. Truncated to 240 characters; full text on the upstream profile.

Official profile

The full record on the Joint Transparency Register carries financial information (lobby budget, EU funding received), the list of named accredited representatives, declared interests of those persons, and a history of meetings with Commission officials.

Registered

2024-09-20

Last updated

2026-04-07

Other Companies & groups in United States

Other registered organisations in United States

Frequently asked questions

What is this organisation?
Regeneron Pharmaceuticals Inc. is an interest representative listed in the EU Joint Transparency Register under ID 045767293922-02. Entity form: Corporation.
What category is it registered under?
It is registered under the category "Companies & groups".
Which country is it based in?
The organisation is based in United States, Tarrytown.
What are its stated goals?
As declared by the registrant: Regeneron is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, Regeneron's unique ability to repeatedly and cons…
Where can I find its EU Transparency Register entry?
The full register entry — including lobby budget, EU funding received, accredited representatives and Commission meetings — is available on the EU Transparency Register under ID 045767293922-02.

Source: EU Joint Transparency Register (Council / Commission / Parliament) · refreshed 2026-07-09 · Commission Reuse Decision 2011/833/EU